论文部分内容阅读
目的:分析氯吡格雷治疗不稳定性心绞痛的临床效果及安全性。方法:将我院2013年3月至2015年4月接受治疗的1020例不稳定型心绞痛患者随机分为治疗组及对照组,各510例;两组患者均给予镇痛、吸氧、抗心律失常个常规治疗,在此基础上,观察组给予氯吡格雷进行治疗,对两组患者治疗总有效率及不良反应发生率进行比较和分析。结果:观察组患者总有效率(91.4%)显著高于对照组(82.7%),差异有统计学意义(p<0.05);不良反应发生率两组差异无统计学意义(P>0.05)。结论:氯吡格雷辅助常规药物治疗不稳定型心绞痛效果显著,不良反应较少,安全性高,疗效值得肯定。
Objective: To analyze the clinical effect and safety of clopidogrel in the treatment of unstable angina pectoris. Methods: A total of 1020 patients with unstable angina who were treated in our hospital from March 2013 to April 2015 were randomly divided into treatment group and control group, with 510 cases in each group. Patients in both groups were given analgesia, oxygen inhalation and antiarrhythmic Unconventional conventional treatment, on this basis, the observation group was treated with clopidogrel, the total effective rate of treatment of both groups and the incidence of adverse reactions were compared and analyzed. Results: The total effective rate (91.4%) in the observation group was significantly higher than that in the control group (82.7%), the difference was statistically significant (p <0.05). The incidence of adverse reactions was no significant difference between the two groups (P> 0.05). Conclusion: Clopidogrel adjuvant conventional drugs for the treatment of unstable angina pectoris has significant effect, less adverse reactions, high safety, efficacy is worthy of recognition.